How far does a new horizon extend for rucaparib in metastatic prostate cancer?
| Errataetall: |
CommentOn: N Engl J Med. 2023 Feb 23;388(8):719-732. - PMID 36795891 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Translational cancer research - 13(2024), 1 vom: 31. Jan., Seite 11-14 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Karzai, Fatima [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 29.02.2024 published: Print-Electronic CommentOn: N Engl J Med. 2023 Feb 23;388(8):719-732. - PMID 36795891 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.21037/tcr-23-1563 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369001885 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369001885 | ||
| 003 | DE-627 | ||
| 005 | 20240229235246.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21037/tcr-23-1563 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1311.xml |
| 035 | |a (DE-627)NLM369001885 | ||
| 035 | |a (NLM)38410224 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Karzai, Fatima |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a How far does a new horizon extend for rucaparib in metastatic prostate cancer? |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 29.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: N Engl J Med. 2023 Feb 23;388(8):719-732. - PMID 36795891 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a BRCA | |
| 650 | 4 | |a Rucaparib | |
| 650 | 4 | |a metastatic | |
| 650 | 4 | |a prostate cancer | |
| 700 | 1 | |a Madan, Ravi A |e verfasserin |4 aut | |
| 700 | 1 | |a Figg, William D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Translational cancer research |d 2012 |g 13(2024), 1 vom: 31. Jan., Seite 11-14 |w (DE-627)NLM219999724 |x 2219-6803 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2024 |g number:1 |g day:31 |g month:01 |g pages:11-14 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.21037/tcr-23-1563 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2024 |e 1 |b 31 |c 01 |h 11-14 | ||